首页 > 最新文献

Przeglad lekarski最新文献

英文 中文
Long-term follow-up after Holmium:YAG laser revascularization combined with autologous bone marrow derived stem cells implantation. 钬:YAG激光血管重建术联合自体骨髓源性干细胞移植术后的长期随访。
Pub Date : 2017-01-01
Janusz Konstanty-Kalandyk, Jacek Piątek, Anna Kędziora, Tomasz Miszalski-Jamka, Bogusław Kapelak, Krzysztof Bartuś, Tomasz Darocha, Rafał Drwiła, Jerzy Sadowski

Background: Coronary artery diseaseis a major cause of death worldwide.Despite different standard revascularizationoptions, significant numberof patients remains not suitable for anytreatment. The aim of the study was toevaluate long-term outcome of patientswith diffuse coronary artery disease,treated with autologous stem cells injectionscombined with transmyocardiallaser revascularization.

Material and methods: 9 patients underwentHolmium:YAG laser revascularizationand autologous bone marrowderived stem cells implantation between2007 and 2009 in the Department of CardiovascularSurgery and Transplantology,John Paul II Hospital, Kraków andwere subsequently followed up in 2015.

Results: The mean follow-up periodwas 73 months. The mean CCSclass significantly improved (1.4±0.5vs 3.3±1.0; p<0.001) and cardiac relatedhospitalizations significantly decreased(1.1±0.8 vs 3.1±2.1; p<0.001). One deathdue to heart failure was observed. Themean LVEF increased from 38% to 42%(p>0.05).

Conclusions: Clinical status improvementwas observed with low mortalityrate in the long-term follow-up. Nonew regional wall motion abnormalitieswere observed, and the increase ofglobal ejection fraction was noted.

背景:冠状动脉疾病是世界范围内死亡的主要原因之一。尽管有不同的标准血运重建选择,但仍有相当数量的患者不适合任何治疗。该研究的目的是评估弥漫性冠状动脉疾病患者接受自体干细胞注射联合经心肌激光血管重建术治疗的长期疗效。材料和方法:2007年至2009年在约翰保罗二世医院(Kraków)心血管外科和移植科接受钬激光血管重建术和自体骨髓源性干细胞植入的9例患者,并于2015年随访。结果:平均随访73个月。ccs平均分级显著提高(1.4±0.5vs 3.3±1.0;p0.05)。结论:经长期随访,患者临床状况改善,病死率低。未观察到新的区域壁面运动异常,整体射血分数增加。
{"title":"Long-term follow-up after Holmium:YAG laser revascularization combined with autologous bone marrow derived stem cells implantation.","authors":"Janusz Konstanty-Kalandyk,&nbsp;Jacek Piątek,&nbsp;Anna Kędziora,&nbsp;Tomasz Miszalski-Jamka,&nbsp;Bogusław Kapelak,&nbsp;Krzysztof Bartuś,&nbsp;Tomasz Darocha,&nbsp;Rafał Drwiła,&nbsp;Jerzy Sadowski","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Coronary artery disease\u0000is a major cause of death worldwide.\u0000Despite different standard revascularization\u0000options, significant number\u0000of patients remains not suitable for any\u0000treatment. The aim of the study was to\u0000evaluate long-term outcome of patients\u0000with diffuse coronary artery disease,\u0000treated with autologous stem cells injections\u0000combined with transmyocardial\u0000laser revascularization.</p><p><strong>Material and methods: </strong>9 patients underwent\u0000Holmium:YAG laser revascularization\u0000and autologous bone marrow\u0000derived stem cells implantation between\u00002007 and 2009 in the Department of Cardiovascular\u0000Surgery and Transplantology,\u0000John Paul II Hospital, Kraków and\u0000were subsequently followed up in 2015.</p><p><strong>Results: </strong>The mean follow-up period\u0000was 73 months. The mean CCS\u0000class significantly improved (1.4±0.5\u0000vs 3.3±1.0; p<0.001) and cardiac related\u0000hospitalizations significantly decreased\u0000(1.1±0.8 vs 3.1±2.1; p<0.001). One death\u0000due to heart failure was observed. The\u0000mean LVEF increased from 38% to 42%\u0000(p>0.05).</p><p><strong>Conclusions: </strong>Clinical status improvement\u0000was observed with low mortality\u0000rate in the long-term follow-up. No\u0000new regional wall motion abnormalities\u0000were observed, and the increase of\u0000global ejection fraction was noted.</p>","PeriodicalId":21148,"journal":{"name":"Przeglad lekarski","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36045765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Klotho not only antiageing protein]. [克洛索不仅仅是抗衰老蛋白]。
Pub Date : 2017-01-01
Bartosz Sosnowski, Hanna Bachórzewska-Gajewska, Slawomir Dobrzycki, Jolanta Malyszko

Klotho, the gene encoding theantiaging protein, was discovered in1997 and named after a Greek Goddeswho spun the thread of life. Numerousexperiments on mice confirmed thatdestruction of the klotho gene or lossof klotho function leads to an acceleratedaging and premature death.In addition to shortened life span,klotho-deficient mice demonstratedchanges in functioning of multipleorgans, ectopic calcification, enhanceddevelopment of arteriosclerosis,osteoporosis and atrophy of skin. Incontrast, overexpression of a gene inmice inhibited aging and prolongedsurvival. The multisystemic phenotypeinduced by Klotho deficiency indicatesthat Klotho works on a variety oforgans. Klotho is highly expressedin the kidney, brain, and to a lesserextent in other organs. Protein Klothoexists in two forms: membrane andsecreted which play different functions.Membrane Klotho function asan obligate co-receptor required forsignaling for the phosphaturic factorFGF23, regulates calcium-phosphatehomeostasis through renal ion transportin addition to modulation of PTHand 1,25(OH)2D3. Soluble klotho functionsas a humoral factor and regulatesthe activity of several ion channels andtransporters. The secreted Klotho canalso inhibit oxydative stres and theinsulin and insulin-like growth factor 1(IGF-1) pathways. The discovery of theprotein klotho led to the identificationof new axes connecting endocrinedisturbances in the homeostasis ofthe calcium-phosphate to the aging ofthe organism. Klotho deficiency maynot only be a trigger for acceleratedaging but also in development of age--associated diseases, including hypertension,osteoporosis, cardiovasculardisease, and CKD. Conceivably, betterunderstanding of Klotho protein mightprovide a novel treatment strategy foraging and age-associated diseases.

编码抗衰老蛋白的基因Klotho于1997年被发现,并以一位编织生命之线的希腊女神命名。在老鼠身上进行的大量实验证实,klotho基因的破坏或klotho功能的丧失会导致加速衰老和过早死亡。除了寿命缩短外,klotho缺陷小鼠在多器官功能、异位钙化、动脉硬化、骨质疏松和皮肤萎缩方面表现出变化。相反,在小鼠中过度表达一种基因可以抑制衰老并延长存活时间。由Klotho缺乏症引起的多系统表型表明,Klotho作用于多种器官。Klotho在肾脏、大脑中高度表达,在其他器官中表达较少。蛋白质以膜和分泌两种形式存在,发挥着不同的功能。膜Klotho功能是磷酸化因子fgf23信号传递所需的专性共受体,通过肾离子转运蛋白调节磷酸钙稳态,并调节pand 1,25(OH)2D3。可溶性氯离子是一种体液因子,可调节多种离子通道和转运体的活性。分泌的Klotho也可以抑制氧化应激及其胰岛素和胰岛素样生长因子1(IGF-1)途径。klotho蛋白的发现导致了将磷酸钙体内平衡中的内分泌紊乱与生物体衰老联系起来的新轴的确定。Klotho缺乏症不仅可能是加速衰老的诱因,而且还可能引发与年龄相关的疾病,包括高血压、骨质疏松症、心血管疾病和慢性肾病。可以想象,更好地了解Klotho蛋白可能会为觅食和年龄相关疾病提供一种新的治疗策略。
{"title":"[Klotho not only antiageing protein].","authors":"Bartosz Sosnowski,&nbsp;Hanna Bachórzewska-Gajewska,&nbsp;Slawomir Dobrzycki,&nbsp;Jolanta Malyszko","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Klotho, the gene encoding the\u0000antiaging protein, was discovered in\u00001997 and named after a Greek Goddes\u0000who spun the thread of life. Numerous\u0000experiments on mice confirmed that\u0000destruction of the klotho gene or loss\u0000of klotho function leads to an accelerated\u0000aging and premature death.\u0000In addition to shortened life span,\u0000klotho-deficient mice demonstrated\u0000changes in functioning of multiple\u0000organs, ectopic calcification, enhanced\u0000development of arteriosclerosis,\u0000osteoporosis and atrophy of skin. In\u0000contrast, overexpression of a gene in\u0000mice inhibited aging and prolonged\u0000survival. The multisystemic phenotype\u0000induced by Klotho deficiency indicates\u0000that Klotho works on a variety of\u0000organs. Klotho is highly expressed\u0000in the kidney, brain, and to a lesser\u0000extent in other organs. Protein Klotho\u0000exists in two forms: membrane and\u0000secreted which play different functions.\u0000Membrane Klotho function as\u0000an obligate co-receptor required for\u0000signaling for the phosphaturic factor\u0000FGF23, regulates calcium-phosphate\u0000homeostasis through renal ion transport\u0000in addition to modulation of PTH\u0000and 1,25(OH)2D3. Soluble klotho functions\u0000as a humoral factor and regulates\u0000the activity of several ion channels and\u0000transporters. The secreted Klotho can\u0000also inhibit oxydative stres and the\u0000insulin and insulin-like growth factor 1\u0000(IGF-1) pathways. The discovery of the\u0000protein klotho led to the identification\u0000of new axes connecting endocrine\u0000disturbances in the homeostasis of\u0000the calcium-phosphate to the aging of\u0000the organism. Klotho deficiency may\u0000not only be a trigger for accelerated\u0000aging but also in development of age-\u0000-associated diseases, including hypertension,\u0000osteoporosis, cardiovascular\u0000disease, and CKD. Conceivably, better\u0000understanding of Klotho protein might\u0000provide a novel treatment strategy for\u0000aging and age-associated diseases.</p>","PeriodicalId":21148,"journal":{"name":"Przeglad lekarski","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36042810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[CyberKnife for prostate cancer patients. Update of 200 patients treatment results]. 前列腺癌患者的射波刀。更新200例患者的治疗结果]。
Pub Date : 2017-01-01
Leszek Miszczyk, Aleksandra Napieralska, Agnieszka Namysł-Kaletka, Grzegorz Woźniak, Małgorzata Stapór-Fudzińska, Grzegorz Głowacki, Andrzej Tukiendorf

Introduction: This is an update regardingthe treatment results of 200prostate cancer patients’ (PCP) CyberKnifebased radioablation (the firstgroup in Poland).The purpose of this study is reevaluation(after 2 years) of this treatmentmodality results of low (LR) andintermediate risk (IR) (including T2c)PCP and failure analysis.

Material and methods: 200 PCP (95LR, 86 IR, 19 T2c) 53 – 83 y.o. (mean 69)treated between 2011 and 2014. 48%used neoadjuvant ADT. The patientswere irradiated every other day witha fraction dose of 7.25 Gy to the totaldose 36.25 Gy (5 fractions in 9 days).Fiducials based tracking was performed.The patients were controlledon the treatment completion day, 1, 4,8 months later and subsequently every6 months. The PSA concentration,ADT usage, acute and late adverse effects(EORTC/RTOG) and other symptomswere evaluated. FU ranged from1 to 63.6 months (mean 32.2, median32.9).

Results: The adverse effects percentagewas very low; only 1 monthafter treatment the percentage ofacute urinary reaction exceeded 40%.Only single G3 adverse effects werenoted. Over 4 months the medianPSA concentration declined from 3.75to 0.27 ng/ml. 9 failures (4.5%) werenoted – more among IR and patientswithout neoadjuvant ADT. No failurein the T2c group was found. Mediantime to failure was 32.4 months. Coxanalysis revealed that the failure riskincreases with the value of maximalPSA before treatment.

Conclusions: CK based radioablation of LR andIR PCP is a safe and highly effectivetreatment modality.The main prognostic factor of failureafter this treatment is probablythe maximal PSA concentration beforetreatment.The neoadjuvant ADT in IR groupshould be considered.The lack of failures in the T2c group enables us to suggestthat even more locally advanced patients (T3) withlow PSA and maximal Gleason 3+4 could be treated withthis modality.

简介:这是关于200名前列腺癌患者(PCP)基于cyberknife的放射消融治疗结果的更新(波兰的第一组)。本研究的目的是重新评估(2年后)这种治疗方式的低(LR)和中风险(IR)(包括T2c)PCP结果和失败分析。材料和方法:2011年至2014年治疗的200例PCP (95LR, 86 IR, 19 T2c) 53 - 83例(平均69例)。48%采用新辅助ADT。每隔一天接受一次7.25 Gy至36.25 Gy的部分剂量照射,共9天5次。进行了基于基准的跟踪。分别于治疗结束当天、1、4、8个月及以后每6个月进行对照。观察两组患者PSA浓度、ADT用量、急性和晚期不良反应(EORTC/RTOG)及其他症状。FU范围为1 ~ 63.6个月(平均32.2个月,中位32.9个月)。结果:不良反应发生率极低;治疗后仅1个月,急性尿反应率超过40%。仅注意到单个G3不良反应。4个月后,中位psa浓度从3.75 ng/ml下降到0.27 ng/ml。9例失败(4.5%)被注意到-在IR和没有新辅助ADT的患者中更多。T2c组未见治疗失败。到失败的中位时间为32.4个月。联合分析显示,治疗前psa值越高,治疗失败的风险越高。结论:以CK为基础放射消融LR和dir PCP是一种安全、高效的治疗方法。治疗失败的主要预后因素可能是治疗前的最大PSA浓度。IR组应考虑新辅助ADT。T2c组没有失败,这使我们认为,即使是更低PSA和最大Gleason 3+4的局部晚期患者(T3)也可以采用这种方式治疗。
{"title":"[CyberKnife for prostate cancer patients. Update of 200 patients treatment results].","authors":"Leszek Miszczyk,&nbsp;Aleksandra Napieralska,&nbsp;Agnieszka Namysł-Kaletka,&nbsp;Grzegorz Woźniak,&nbsp;Małgorzata Stapór-Fudzińska,&nbsp;Grzegorz Głowacki,&nbsp;Andrzej Tukiendorf","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>This is an update regarding\u0000the treatment results of 200\u0000prostate cancer patients’ (PCP) CyberKnife\u0000based radioablation (the first\u0000group in Poland).\u0000The purpose of this study is reevaluation\u0000(after 2 years) of this treatment\u0000modality results of low (LR) and\u0000intermediate risk (IR) (including T2c)\u0000PCP and failure analysis.</p><p><strong>Material and methods: </strong>200 PCP (95\u0000LR, 86 IR, 19 T2c) 53 – 83 y.o. (mean 69)\u0000treated between 2011 and 2014. 48%\u0000used neoadjuvant ADT. The patients\u0000were irradiated every other day with\u0000a fraction dose of 7.25 Gy to the total\u0000dose 36.25 Gy (5 fractions in 9 days).\u0000Fiducials based tracking was performed.\u0000The patients were controlled\u0000on the treatment completion day, 1, 4,\u00008 months later and subsequently every\u00006 months. The PSA concentration,\u0000ADT usage, acute and late adverse effects\u0000(EORTC/RTOG) and other symptoms\u0000were evaluated. FU ranged from\u00001 to 63.6 months (mean 32.2, median\u000032.9).</p><p><strong>Results: </strong>The adverse effects percentage\u0000was very low; only 1 month\u0000after treatment the percentage of\u0000acute urinary reaction exceeded 40%.\u0000Only single G3 adverse effects were\u0000noted. Over 4 months the median\u0000PSA concentration declined from 3.75\u0000to 0.27 ng/ml. 9 failures (4.5%) were\u0000noted – more among IR and patients\u0000without neoadjuvant ADT. No failure\u0000in the T2c group was found. Median\u0000time to failure was 32.4 months. Cox\u0000analysis revealed that the failure risk\u0000increases with the value of maximal\u0000PSA before treatment.</p><p><strong>Conclusions: </strong>CK based radioablation of LR and\u0000IR PCP is a safe and highly effective\u0000treatment modality.\u0000The main prognostic factor of failure\u0000after this treatment is probably\u0000the maximal PSA concentration before\u0000treatment.\u0000The neoadjuvant ADT in IR group\u0000should be considered.\u0000The lack of failures in the T2c group enables us to suggest\u0000that even more locally advanced patients (T3) with\u0000low PSA and maximal Gleason 3+4 could be treated with\u0000this modality.</p>","PeriodicalId":21148,"journal":{"name":"Przeglad lekarski","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36044334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of gender on the frequency of syncope provoking factors and prodromal signs in patients with vasovagal syncope. 性别对血管迷走神经性晕厥患者晕厥诱发因素频率及前驱症状的影响。
Pub Date : 2017-01-01
Katarzyna Cubera, Piotr J Stryjewski, Agnieszka Kuczaj, Jadwiga Nessler, Ewa Nowalany-Kozielska, Jolanta Pytko-Polończyk

Introduction: According to theESC guidelines, syncope is a transientloss of consciousness causedby transient, general cerebral hypoperfusion,characterized by rapid onset,short duration and spontaneousrecovery.

Objectives: The aim of the studywas a comparative analysis of syncopeprovoking factors and prodromalsigns in patients with vasovagalsyncope with consideration given togender.

Materials and methods: We investigated 80 patients, aged 18-74years with previously diagnosedvasovagal cause of syncope. Specialattention was paid to the frequencyof triggering factors and prodromal signs.

Results: In the studied group themean age at first syncope was significantlylower in women (23.2±10.7)as compared to men (30.7±17.4).The mean total number of syncopaland presyncopal episodes was significantlyhigher in women (13.3±11.0vs. 7.8±6.6; 26.6±12.9 vs. 13.8±6.9). Inthe group of men syncopal episodeswere more frequent after urinationand defecation. The remainingcircumstances related to syncopewere more prevalent in women, butonly the occurrence of a syncopalepisode during walking achievedstatistical significance. All the prodromalsigns that were analysed occurredmore frequently in the groupof women compared to men. Statisticalsignificance was achieved for theanalysed signs such as generalizedweakness, dyspnea, heart palpitations,cold sweats, feeling of cold orheat, visual disturbances, tinnitus,headache.

Conclusions: Syncope provokingfactors and prodromal signs occurmore frequently in women.

简介:根据esc指南,晕厥是一种由短暂性、全面性脑灌注不足引起的一过性意识丧失,其特点是起病快、持续时间短、自动恢复。目的:本研究的目的是比较分析血管迷走神经性晕厥患者的诱发因素和前驱症状,并考虑性别因素。材料和方法:我们调查了80例既往诊断为迷走神经性晕厥的患者,年龄18-74岁。特别注意触发因素的频率和前驱症状。结果:研究组女性首次晕厥的平均年龄(23.2±10.7)明显低于男性(30.7±17.4)。女性的晕厥和晕厥前发作的平均总次数(13.3±11.0)明显高于男性。7.8±6.6;26.6±12.9 vs. 13.8±6.9)。在男性组中,晕厥发作在排尿和排便后更为频繁。与晕厥相关的其他情况在女性中更为普遍,但只有走路时晕厥发作的发生具有统计学意义。与男性相比,所有的前驱症状在女性群体中出现的频率更高。分析的体征如全身无力、呼吸困难、心悸、冷汗、冷或热感、视觉障碍、耳鸣、头痛等均有统计学意义。结论:晕厥诱发因素和前驱症状在女性中更为常见。
{"title":"The impact of gender on the frequency of syncope provoking factors and prodromal signs in patients with vasovagal syncope.","authors":"Katarzyna Cubera,&nbsp;Piotr J Stryjewski,&nbsp;Agnieszka Kuczaj,&nbsp;Jadwiga Nessler,&nbsp;Ewa Nowalany-Kozielska,&nbsp;Jolanta Pytko-Polończyk","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>According to the\u0000ESC guidelines, syncope is a transient\u0000loss of consciousness caused\u0000by transient, general cerebral hypoperfusion,\u0000characterized by rapid onset,\u0000short duration and spontaneous\u0000recovery.</p><p><strong>Objectives: </strong>The aim of the study\u0000was a comparative analysis of syncope\u0000provoking factors and prodromal\u0000signs in patients with vasovagal\u0000syncope with consideration given to\u0000gender.</p><p><strong>Materials and methods: </strong>We investigated 80 patients, aged 18-74\u0000years with previously diagnosed\u0000vasovagal cause of syncope. Special\u0000attention was paid to the frequency\u0000of triggering factors and prodromal signs.</p><p><strong>Results: </strong>In the studied group the\u0000mean age at first syncope was significantly\u0000lower in women (23.2±10.7)\u0000as compared to men (30.7±17.4).\u0000The mean total number of syncopal\u0000and presyncopal episodes was significantly\u0000higher in women (13.3±11.0\u0000vs. 7.8±6.6; 26.6±12.9 vs. 13.8±6.9). In\u0000the group of men syncopal episodes\u0000were more frequent after urination\u0000and defecation. The remaining\u0000circumstances related to syncope\u0000were more prevalent in women, but\u0000only the occurrence of a syncopal\u0000episode during walking achieved\u0000statistical significance. All the prodromal\u0000signs that were analysed occurred\u0000more frequently in the group\u0000of women compared to men. Statistical\u0000significance was achieved for the\u0000analysed signs such as generalized\u0000weakness, dyspnea, heart palpitations,\u0000cold sweats, feeling of cold or\u0000heat, visual disturbances, tinnitus,\u0000headache.</p><p><strong>Conclusions: </strong>Syncope provoking\u0000factors and prodromal signs occur\u0000more frequently in women.</p>","PeriodicalId":21148,"journal":{"name":"Przeglad lekarski","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36044571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oral mucosa lesions in patients with active Crohn’s disease - a prospective study. 活动期克罗恩病患者口腔黏膜病变的前瞻性研究
Pub Date : 2017-01-01
Katarzyna Szczeklik, Jolanta Pytko-Polończyk, Dorota Cibor, Danuta Owczarek, Tomasz Mach

Introduction: Crohn’s disease (CD)is a chronic inflammatory disease,which may involve any part of the gastrointestinaltract, including the oralcavity. Mucosal lesions in the oral cavityare described in various populations,but observations in active diseasewith severe clinical symptoms arequite rare.

Objectives: To evaluate the prevalenceand nature of oral mucosa lesionsin adult patients with active CDand their correlation with clinical andlaboratory indicators of disease activity.

Material and methods: Prospectivestudy was performed in 62 patients(29 women, 33 men, age 18-49 years)admitted between December 2010 andFebruary 2013 to the gastroenterologydepartment with a confirmed diagnosisof CD and exacerbations of symptoms,and 40 sex- and gender-matchedhealthy volunteers. CD activity wasclassified according to clinical andblood parameters, and the CD activityindex (CDAI). We examined: blood morphology,hemoglobin and CRP levels,BMI. Examination of the oral cavity includeda detailed interview and physicalexamination, based on the WHOrecommendations.

Results: In patients with activeCD we found: increased CDAIscore (258.4±21.5), higher CRP levels(24.6±1.3 mg/l) and platelet count, anemiawith significantly reduced RBC andhemoglobin level, and reduced BMI, incomparison to controls. The specificfor CD symptoms were found in themouth: indurated tag polypoid lesionson vestibular retromolar region in12.9% of patients, cobblestoning of themucosa in 9.7%, diffuse asymptomaticbuccal swelling in 16.2%, mucogingivitisin 19.4% of patients. Oral nonspecificlesions were more frequent: angularcheilitis in 29.1%, atrophic glossitis in14.5% of patients. Oral lesions correlatedwith hemoglobin and CRP concentrations(r=-0.431 and r=0.437; respectively;p<0.001), platelet count (r=0.45;p<0.003), CDAI (r=0.421; p<0.001) andBMI (r=0.307; p<0.006). No correlationhas been found between specific ornon-specific lesions and location ofinflammatory changes in the gastrointestinaltract.

Conclusions: Changes in the oral mucosa in adult patientswith active CD are frequent. They should be correlatedwith other clinical symptoms of gastrointestinal tract and biochemicalparameters in patients with CD. The nature of thesechanges may have an impact on the further therapeutic approach.

简介:克罗恩病(CD)是一种慢性炎症性疾病,可累及胃肠道的任何部位,包括口腔。口腔粘膜病变在各种人群中都有报道,但在有严重临床症状的活动性疾病中观察到的情况相当罕见。目的:探讨成人活动性cdp患者口腔黏膜病变的发生率、性质及其与临床、实验室疾病活动性指标的相关性。材料和方法:前瞻性研究纳入了2010年12月至2013年2月期间肠胃科确诊为乳糜泻和症状加重的62例患者(29例女性,33例男性,年龄18-49岁),以及40名性别和性别匹配的健康志愿者。根据临床和血液指标及CD活性指数(CDAI)对CD活性进行分类。我们检查了:血液形态,血红蛋白和CRP水平,BMI。口腔检查包括详细的面谈和体格检查,根据世界卫生组织的建议。结果:在activeCD患者中,我们发现:与对照组相比,CDAIscore(258.4±21.5)升高,CRP水平(24.6±1.3 mg/l)和血小板计数升高,贫血,RBC和血红蛋白水平显著降低,BMI降低。乳糜泻症状的特异性见于口腔:12.9%的患者前庭后磨牙区出现硬化标记息肉样病变,9.7%的患者出现粘膜鹅卵石样病变,16.2%的患者出现弥漫性无症状颊肿胀,19.4%的患者出现粘膜炎。口腔非特异性病变更为常见:29.1%的患者患有牙根角炎,14.5%的患者患有萎缩性舌炎。口腔病变与血红蛋白、CRP浓度相关(r=-0.431、r=0.437;结论:成人活动性CD患者口腔黏膜变化频繁。它们应与乳糜泻患者胃肠道的其他临床症状和生化参数相关。这些变化的性质可能对进一步的治疗方法产生影响。
{"title":"Oral mucosa lesions in patients with active Crohn’s disease - a prospective study.","authors":"Katarzyna Szczeklik,&nbsp;Jolanta Pytko-Polończyk,&nbsp;Dorota Cibor,&nbsp;Danuta Owczarek,&nbsp;Tomasz Mach","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Crohn’s disease (CD)\u0000is a chronic inflammatory disease,\u0000which may involve any part of the gastrointestinal\u0000tract, including the oral\u0000cavity. Mucosal lesions in the oral cavity\u0000are described in various populations,\u0000but observations in active disease\u0000with severe clinical symptoms are\u0000quite rare.</p><p><strong>Objectives: </strong>To evaluate the prevalence\u0000and nature of oral mucosa lesions\u0000in adult patients with active CD\u0000and their correlation with clinical and\u0000laboratory indicators of disease activity.</p><p><strong>Material and methods: </strong>Prospective\u0000study was performed in 62 patients\u0000(29 women, 33 men, age 18-49 years)\u0000admitted between December 2010 and\u0000February 2013 to the gastroenterology\u0000department with a confirmed diagnosis\u0000of CD and exacerbations of symptoms,\u0000and 40 sex- and gender-matched\u0000healthy volunteers. CD activity was\u0000classified according to clinical and\u0000blood parameters, and the CD activity\u0000index (CDAI). We examined: blood morphology,\u0000hemoglobin and CRP levels,\u0000BMI. Examination of the oral cavity included\u0000a detailed interview and physical\u0000examination, based on the WHO\u0000recommendations.</p><p><strong>Results: </strong>In patients with active\u0000CD we found: increased CDAI\u0000score (258.4±21.5), higher CRP levels\u0000(24.6±1.3 mg/l) and platelet count, anemia\u0000with significantly reduced RBC and\u0000hemoglobin level, and reduced BMI, in\u0000comparison to controls. The specific\u0000for CD symptoms were found in the\u0000mouth: indurated tag polypoid lesions\u0000on vestibular retromolar region in\u000012.9% of patients, cobblestoning of the\u0000mucosa in 9.7%, diffuse asymptomatic\u0000buccal swelling in 16.2%, mucogingivitis\u0000in 19.4% of patients. Oral nonspecific\u0000lesions were more frequent: angular\u0000cheilitis in 29.1%, atrophic glossitis in\u000014.5% of patients. Oral lesions correlated\u0000with hemoglobin and CRP concentrations\u0000(r=-0.431 and r=0.437; respectively;\u0000p<0.001), platelet count (r=0.45;\u0000p<0.003), CDAI (r=0.421; p<0.001) and\u0000BMI (r=0.307; p<0.006). No correlation\u0000has been found between specific or\u0000non-specific lesions and location of\u0000inflammatory changes in the gastrointestinal\u0000tract.</p><p><strong>Conclusions: </strong>Changes in the oral mucosa in adult patients\u0000with active CD are frequent. They should be correlated\u0000with other clinical symptoms of gastrointestinal tract and biochemical\u0000parameters in patients with CD. The nature of these\u0000changes may have an impact on the further therapeutic approach.</p>","PeriodicalId":21148,"journal":{"name":"Przeglad lekarski","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36041727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The influence of living conditions and lifestyle on the anxiety level in women in the postpartum period-questionnaire study]. 生活条件和生活方式对产后妇女焦虑水平的影响-问卷研究
Pub Date : 2017-01-01
Barbara Piech, Marta Kiałka, Anna Baran, Sandra Mrozińska, Marek Janeczko, Ewa Humeniuk, Tomasz Milewicz

Introduction: Due to the high incidence of postpartum anxiety disorders and their serious health and social consequences, it is essential to analyze the possible risk factors to identify groups of women particularly vulnerable to cover their proper care and control. The aim of our study was to investigate the relationship between the anxiety in women in the postpartum period, and their living conditions and lifestyle.

Materials and methods: The study was conducted from April to July 2016. We included 102 women in the postpartum period, living in the city of Cracow and the Cracow district. The study was based on a survey of our own authorship, State Anxiety Inventory (STAI) and the Jurczyński’s Inventory of Health Behavior (IZZ).

Results: The anxiety level in women in the postpartum period depends on the conditions of life and health behaviors. The level of health behavior of women in the postpartum period is an average and independent of age, number of children, and the material situation. Residents of cities, women with higher education, who planned pregnancy, have a higher level of health behavior. Good housing conditions have a positive influence on health behavior. Low levels of health behavior significantly affect the severity of maternal anxiety. Residents of the village, women with lower education and who not planning pregnancy have higher levels of anxiety during the postpartum period. Anxiety level of women in the postpartum period is inversely proportional to their housing conditions. Women with a job have lower levels of anxiety than non-working. The anxiety level in women in childbirth does not depend on age or financial situation.

Conclusions: The anxiety level in women in the postpartum period, significantly depends on the living conditions and health behaviors. Verification of distinguished factors should be applied appropriately in health promotional activities and prevention programs.

导言:由于产后焦虑症的高发病率及其严重的健康和社会后果,有必要分析可能的风险因素,以确定特别容易受到适当照顾和控制的妇女群体。本研究旨在探讨产后女性焦虑与生活状况及生活方式的关系。材料与方法:研究时间为2016年4月- 7月。我们包括102名产后妇女,生活在克拉科夫市和克拉科夫区。这项研究是基于我们自己的一项调查,状态焦虑量表(STAI)和Jurczyński的健康行为量表(IZZ)。结果:产后妇女的焦虑水平与生活状况和健康行为有关。产后妇女的健康行为水平是一个平均水平,与年龄、子女数量和物质状况无关。城市居民、受过高等教育、有计划怀孕的女性,健康行为水平更高。良好的住房条件对健康行为有积极影响。低水平的健康行为显著影响产妇焦虑的严重程度。该村居民、受教育程度较低和不计划怀孕的妇女在产后焦虑程度较高。产后妇女的焦虑程度与其住房条件成反比。有工作的女性比没有工作的女性焦虑程度要低。妇女分娩时的焦虑程度并不取决于年龄或经济状况。结论:产后妇女的焦虑水平与生活条件和健康行为有显著关系。在健康促进活动和预防计划中,应适当地应用鉴别因素的验证。
{"title":"[The influence of living conditions and lifestyle on the anxiety level in women in the postpartum period-questionnaire study].","authors":"Barbara Piech,&nbsp;Marta Kiałka,&nbsp;Anna Baran,&nbsp;Sandra Mrozińska,&nbsp;Marek Janeczko,&nbsp;Ewa Humeniuk,&nbsp;Tomasz Milewicz","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Due to the high incidence of postpartum anxiety disorders and their serious health and social consequences, it is essential to analyze the possible risk factors to identify groups of women particularly vulnerable to cover their proper care and control. The aim of our study was to investigate the relationship between the anxiety in women in the postpartum period, and their living conditions and lifestyle.</p><p><strong>Materials and methods: </strong>The study was conducted from April to July 2016. We included 102 women in the postpartum period, living in the city of Cracow and the Cracow district. The study was based on a survey of our own authorship, State Anxiety Inventory (STAI) and the Jurczyński’s Inventory of Health Behavior (IZZ).</p><p><strong>Results: </strong>The anxiety level in women in the postpartum period depends on the conditions of life and health behaviors. The level of health behavior of women in the postpartum period is an average and independent of age, number of children, and the material situation. Residents of cities, women with higher education, who planned pregnancy, have a higher level of health behavior. Good housing conditions have a positive influence on health behavior. Low levels of health behavior significantly affect the severity of maternal anxiety. Residents of the village, women with lower education and who not planning pregnancy have higher levels of anxiety during the postpartum period. Anxiety level of women in the postpartum period is inversely proportional to their housing conditions. Women with a job have lower levels of anxiety than non-working. The anxiety level in women in childbirth does not depend on age or financial situation.</p><p><strong>Conclusions: </strong>The anxiety level in women in the postpartum period, significantly depends on the living conditions and health behaviors. Verification of distinguished factors should be applied appropriately in health promotional activities and prevention programs.</p>","PeriodicalId":21148,"journal":{"name":"Przeglad lekarski","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36045762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Postpartum thyroiditis as the first clinical manifestation of autoimmune polyendocrine syndrome type 2 – case report]. 产后甲状腺炎为首发临床表现的自身免疫性多内分泌综合征2型1例报告。
Pub Date : 2017-01-01
Robert Krysiak, Karolina Kowalcze, Bogusław Okopień

Postpartum thyroiditis is a formof autoimmune thyroiditis developingduring the first 12 months postpartumin 5-10% of women as a consequenceof the immunologic flarefollowing the immune suppressionof pregnancy. Autoimmune polyendocrinesyndromes are rarely diagnosedconditions characterized bythe association of at least two organspecificautoimmune disorders, andon the basis of their clinical picture,they may be divided into four differenttypes. The underestimation oftheir real frequency probable resultsfrom physicians’ inadequate knowledgeof these clinical entities andsometimes their atypical clinical picture.Although autoimmune thyroiddisease may be a component of bothtype 2 and 3 autoimmune polyendocrinesyndromes, but the associationbetween postpartum thyroiditisand autoimmune conditions of otherendocrine organs has very rarelybeen described in literature. We reporta case of a young woman, whoafter two subsequent pregnanciesdeveloped postpartum thyroiditisof different clinical pictures. Afterher second pregnancy, postpartumthyroiditis was followed by the developmentof autoimmune adrenalfailure and premature ovarian failure,which allowed to diagnose type 2 autoimmunepolyendocrine syndrome.Our case study suggests that everyperson with postpartum thyroiditis,particularly if this disorder is accompaniedby atypical clinical manifestation,should be assessed for thepossible presence of autoimmunepolyendocrine syndrome.

产后甲状腺炎是一种自身免疫性甲状腺炎,发生在产后12个月,5-10%的妇女因妊娠免疫抑制后出现免疫症状。自身免疫性多内分泌综合征很少被诊断为至少两种器官特异性自身免疫性疾病相关的疾病,根据其临床表现,它们可分为四种不同的类型。对其真实频率的低估可能是由于医生对这些临床实体的知识不足,有时是他们的非典型临床表现。虽然自身免疫性甲状腺疾病可能是2型和3型自身免疫性多内分泌综合征的一个组成部分,但产后甲状腺疾病与其他内分泌器官自身免疫性疾病之间的关系很少有文献报道。我们报告一例年轻妇女,谁后两次妊娠发展产后甲状腺炎不同的临床表现。在她第二次怀孕后,产后甲状腺炎随后发展为自身免疫性肾上腺功能衰竭和卵巢早衰,从而诊断为2型自身免疫性多内分泌综合征。我们的病例研究表明,每个患有产后甲状腺炎的人,特别是如果这种疾病伴有不典型的临床表现,应该评估是否存在自身免疫性多内分泌综合征。
{"title":"[Postpartum thyroiditis as the first clinical manifestation of autoimmune polyendocrine syndrome type 2 – case report].","authors":"Robert Krysiak,&nbsp;Karolina Kowalcze,&nbsp;Bogusław Okopień","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Postpartum thyroiditis is a form\u0000of autoimmune thyroiditis developing\u0000during the first 12 months postpartum\u0000in 5-10% of women as a consequence\u0000of the immunologic flare\u0000following the immune suppression\u0000of pregnancy. Autoimmune polyendocrine\u0000syndromes are rarely diagnosed\u0000conditions characterized by\u0000the association of at least two organspecific\u0000autoimmune disorders, and\u0000on the basis of their clinical picture,\u0000they may be divided into four different\u0000types. The underestimation of\u0000their real frequency probable results\u0000from physicians’ inadequate knowledge\u0000of these clinical entities and\u0000sometimes their atypical clinical picture.\u0000Although autoimmune thyroid\u0000disease may be a component of both\u0000type 2 and 3 autoimmune polyendocrine\u0000syndromes, but the association\u0000between postpartum thyroiditis\u0000and autoimmune conditions of other\u0000endocrine organs has very rarely\u0000been described in literature. We report\u0000a case of a young woman, who\u0000after two subsequent pregnancies\u0000developed postpartum thyroiditis\u0000of different clinical pictures. After\u0000her second pregnancy, postpartum\u0000thyroiditis was followed by the development\u0000of autoimmune adrenal\u0000failure and premature ovarian failure,\u0000which allowed to diagnose type 2 autoimmune\u0000polyendocrine syndrome.\u0000Our case study suggests that every\u0000person with postpartum thyroiditis,\u0000particularly if this disorder is accompanied\u0000by atypical clinical manifestation,\u0000should be assessed for the\u0000possible presence of autoimmune\u0000polyendocrine syndrome.</p>","PeriodicalId":21148,"journal":{"name":"Przeglad lekarski","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36047838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ocular outcomes in 4-year old prematurely born children. 4岁早产儿的眼部预后。
Pub Date : 2017-01-01
Anna Leśniak, Małgorzata Klimek, Anna Kubatko-Zielińska, Joanna Kobylarz, Magdalena Nitecka, Grażyna Dutkowska, Bożena Romanowska-Dixon, Przemko Kwinta

Purpose: The aim of the study wasto assess functional and structuralophthalmologic outcomes in 4-year oldvery low birth weight children (VLBW).

Material and methods: A group of 82 VLBW children including: (1)children without retinopathy of prematurity– group O (n = 30), (2) childrenwith retinopathy of prematurity with noindications for laser coagulation- group1 (n = 20 ), (3) children with retinopathyof prematurity treated with lasercoagulation – group 2 (n = 32) wereenrolled. Functional (visual acuity,visual evoked potentials, stereopsis,color vision test) and structural (anterioreye segment examination andfundoscopy) outcome, cycloplegicrefraction, intraocular pressure andangle of squint were examined in allchildren. Developmental Test of VisualPerception was also assessed.

Results: Very good visual acuitywas presented in 56 (68.3%) patients,good visual acuity in 11 (13.4%) children,visual acuity between 0.4 and 0.2in 13 (15.9%) and unfavorable function(equal or less than 0.1) was observedin 2 (2.4%) children. Twenty-three patients(28.1%) were myopic, 57 patients(69.5%) were hyperopic. Astigmatism> 1D occurred in 49 (59.8%) patients.Anisometropia larger than 2 D occurredin 7 patients (8.7%). There was nostatistical difference between frequencyof mentioned above complicationsbetween the groups. Abnormal VEPresults were more common (14 children-54%) in group 2 as comparedto other groups (group 0 - 7 children-25%, group 1 – 4 children -24%; p =0.044). Moreover, the lower percentageof group 2 children presented stereopsisvision (46.9%, group 0 – 93.3%,group 1 – 90%; p<0.05). Children withretinopathy of prematurity treated withlaser coagulation had significantlylower Developmental Test of VisualPerceptions scores. In group 1, in 1child naevus pigmentosus of the eyelidwas observed, in group 2 in one childeyeball atrophy in the right eye andaphakia in the left eye were diagnosed.In 1 child in group 0 optic disc drusenwere observed, in 2 children optic discswere pale. In 2 children in group 2retinal detachment stage 5 was diagnosed.

Conclusion: An important factor affecting final ophthalomolgicalassessment in prematurely born children isretinopathy of prematurity treated with laser coagulaion.Children with retinopathy of prematurity without lasercoagulation had examinations results comparable wihchildren without retinopathy of prematurity. Diode laserphotocoagulation is an effective method of treatment fotactive stages of retinopathy of prematurity.

目的:本研究的目的是评估4岁极低出生体重儿(VLBW)的功能和结构的眼科结果。材料与方法:选取82例VLBW患儿,包括:(1)无视网膜病变早产儿O组(n = 30),(2)无激光凝固指征的视网膜病变早产儿1组(n = 20),(3)激光凝固治疗的视网膜病变早产儿2组(n = 32)。检查功能(视力、视觉诱发电位、立体视、色觉)、结构(前眼节检查和眼底镜检查)、睫状体屈光、眼压和斜视角度。对视觉知觉发展测试也进行了评估。结果:56例(68.3%)患儿视力良好,11例(13.4%)患儿视力良好,13例(15.9%)患儿视力在0.4 ~ 0.2之间,2例(2.4%)患儿视力不佳(小于等于0.1)。近视23例(28.1%),远视57例(69.5%)。散光> 1D 49例(59.8%)。屈光参差大于2 D者7例(8.7%)。两组间上述并发症发生频率无统计学差异。与其他组(0 ~ 7组-25%,1 ~ 4组-24%;p = 0.044)。2组儿童立体视发生率较低(46.9%,0 ~ 93.3%,1 ~ 90%;结论:激光凝固治疗早产儿视网膜病变是影响早产儿最终眼科评价的重要因素。未进行激光凝固治疗的早产儿视网膜病变患儿的检查结果与未进行激光凝固治疗的早产儿视网膜病变患儿相当。二极管激光光凝是一种有效的治疗早产儿视网膜病变的方法。
{"title":"Ocular outcomes in 4-year old prematurely born children.","authors":"Anna Leśniak,&nbsp;Małgorzata Klimek,&nbsp;Anna Kubatko-Zielińska,&nbsp;Joanna Kobylarz,&nbsp;Magdalena Nitecka,&nbsp;Grażyna Dutkowska,&nbsp;Bożena Romanowska-Dixon,&nbsp;Przemko Kwinta","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>The aim of the study was\u0000to assess functional and structural\u0000ophthalmologic outcomes in 4-year old\u0000very low birth weight children (VLBW).</p><p><strong>Material and methods: </strong>A group of 82 VLBW children including: (1)\u0000children without retinopathy of prematurity\u0000– group O (n = 30), (2) children\u0000with retinopathy of prematurity with no\u0000indications for laser coagulation- group\u00001 (n = 20 ), (3) children with retinopathy\u0000of prematurity treated with laser\u0000coagulation – group 2 (n = 32) were\u0000enrolled. Functional (visual acuity,\u0000visual evoked potentials, stereopsis,\u0000color vision test) and structural (anterior\u0000eye segment examination and\u0000fundoscopy) outcome, cycloplegic\u0000refraction, intraocular pressure and\u0000angle of squint were examined in all\u0000children. Developmental Test of Visual\u0000Perception was also assessed.</p><p><strong>Results: </strong>Very good visual acuity\u0000was presented in 56 (68.3%) patients,\u0000good visual acuity in 11 (13.4%) children,\u0000visual acuity between 0.4 and 0.2\u0000in 13 (15.9%) and unfavorable function\u0000(equal or less than 0.1) was observed\u0000in 2 (2.4%) children. Twenty-three patients\u0000(28.1%) were myopic, 57 patients\u0000(69.5%) were hyperopic. Astigmatism\u0000> 1D occurred in 49 (59.8%) patients.\u0000Anisometropia larger than 2 D occurred\u0000in 7 patients (8.7%). There was no\u0000statistical difference between frequency\u0000of mentioned above complications\u0000between the groups. Abnormal VEP\u0000results were more common (14 children\u0000-54%) in group 2 as compared\u0000to other groups (group 0 - 7 children\u0000-25%, group 1 – 4 children -24%; p =\u00000.044). Moreover, the lower percentage\u0000of group 2 children presented stereopsis\u0000vision (46.9%, group 0 – 93.3%,\u0000group 1 – 90%; p<0.05). Children with\u0000retinopathy of prematurity treated with\u0000laser coagulation had significantly\u0000lower Developmental Test of Visual\u0000Perceptions scores. In group 1, in 1\u0000child naevus pigmentosus of the eyelid\u0000was observed, in group 2 in one child\u0000eyeball atrophy in the right eye and\u0000aphakia in the left eye were diagnosed.\u0000In 1 child in group 0 optic disc drusen\u0000were observed, in 2 children optic discs\u0000were pale. In 2 children in group 2\u0000retinal detachment stage 5 was diagnosed.</p><p><strong>Conclusion: </strong>An important factor affecting final ophthalomolgical\u0000assessment in prematurely born children is\u0000retinopathy of prematurity treated with laser coagulaion.\u0000Children with retinopathy of prematurity without laser\u0000coagulation had examinations results comparable wih\u0000children without retinopathy of prematurity. Diode laser\u0000photocoagulation is an effective method of treatment fot\u0000active stages of retinopathy of prematurity.</p>","PeriodicalId":21148,"journal":{"name":"Przeglad lekarski","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36042806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The first three docents of urology in Poland]. 波兰最早的三位泌尿科医生。
Pub Date : 2017-01-01
Piotr Kuzaka, Bolesław Kuzaka
{"title":"[The first three docents of urology in Poland].","authors":"Piotr Kuzaka,&nbsp;Bolesław Kuzaka","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21148,"journal":{"name":"Przeglad lekarski","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36044187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Metformin–new potential medicine in pain treatment?] 二甲双胍——治疗疼痛的新潜力药物?]
Pub Date : 2017-01-01
Marta Kiałka, Katarzyna Doroszewska, Marek Janeczko, Tomasz Milewicz

Metformin, a drug of biguanide class, is now one of the most widely used drugs in the treatment of type 2 diabetes. It activates adenosine monophosphate-activated protein kinase (AMPK) and through AMPK activation, inhibits the mammalian target of rapamycin (mTOR) pathway. Recent literature has explored metformin as an option in pain management, given its role in the AMP-activated protein kinase (AMPK) pathway and its ability to modulate pain in animal models. Based on a variety of preclinical pain models, it is now clear that mTOR signaling plays a major role in the sensitization of the nervous system in chronic pain conditions. The activation of AMPK with metformin has led to decreased pain in neuropathic and postsurgical pain models, suggesting that these drugs and this mechanism of actin might be effective in humans. Despite the strong preclinical rationale, there are only very few data considered the utility of metformin as a potential pan therapeutic in humans. Further, randomized studies were needed to identify the role of metformin in pain perception and chronic pain conditions in humans.

二甲双胍是双胍类药物,是目前治疗2型糖尿病最广泛使用的药物之一。它激活腺苷单磷酸活化蛋白激酶(AMPK),并通过AMPK活化,抑制哺乳动物雷帕霉素靶蛋白(mTOR)途径。最近的文献已经探讨了二甲双胍作为疼痛管理的一种选择,考虑到它在amp激活的蛋白激酶(AMPK)途径中的作用及其在动物模型中调节疼痛的能力。基于各种临床前疼痛模型,现在很清楚mTOR信号在慢性疼痛条件下神经系统的敏感化中起着重要作用。二甲双胍激活AMPK导致神经性疼痛和术后疼痛模型的疼痛减轻,这表明这些药物和肌动蛋白的这种机制可能对人类有效。尽管有很强的临床前理论基础,但只有很少的数据考虑二甲双胍作为潜在的人类泛治疗的效用。此外,需要随机研究来确定二甲双胍在人类疼痛感知和慢性疼痛状况中的作用。
{"title":"[Metformin–new potential medicine in pain treatment?]","authors":"Marta Kiałka,&nbsp;Katarzyna Doroszewska,&nbsp;Marek Janeczko,&nbsp;Tomasz Milewicz","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Metformin, a drug of biguanide class, is now one of the most widely used drugs in the treatment of type 2 diabetes. It activates adenosine monophosphate-activated protein kinase (AMPK) and through AMPK activation, inhibits the mammalian target of rapamycin (mTOR) pathway. Recent literature has explored metformin as an option in pain management, given its role in the AMP-activated protein kinase (AMPK) pathway and its ability to modulate pain in animal models. Based on a variety of preclinical pain models, it is now clear that mTOR signaling plays a major role in the sensitization of the nervous system in chronic pain conditions. The activation of AMPK with metformin has led to decreased pain in neuropathic and postsurgical pain models, suggesting that these drugs and this mechanism of actin might be effective in humans. Despite the strong preclinical rationale, there are only very few data considered the utility of metformin as a potential pan therapeutic in humans. Further, randomized studies were needed to identify the role of metformin in pain perception and chronic pain conditions in humans.</p>","PeriodicalId":21148,"journal":{"name":"Przeglad lekarski","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36045763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Przeglad lekarski
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1